TITLE

Metabolic syndrome is not associated with reduction in aortic distensibility in subjects with type 2 diabetes mellitus

AUTHOR(S)
Tentolouris, Nicholas; Papazafiropoulou, Athanasia; Moyssakis, Ioannis; Liatis, Stavros; Perrea, Despoina; Kostakis, Maria; Katsilambros, Nicholas
PUB. DATE
January 2008
SOURCE
Cardiovascular Diabetology;2008, Vol. 7, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Aortic distensibility (AD) is a marker of the elastic properties of the aorta. Reduction of AD occurs early in subjects with type 2 diabetes mellitus (T2DM) and it is associated with subclinical generalized atherosclerosis. Metabolic syndrome (MetS) is common in subjects with T2DM and predicts cardiovascular morbidity and mortality. This study examined the potential relationship between MetS and AD in a cohort of subjects with T2DM. Methods and results: A total of 210 subjects with T2DM were studied. MetS was diagnosed using the NCEP/ATP-III criteria. AD was assessed non-invasively by ultrasonography. The prevalence of MetS was 64.8%. AD was not significantly different between subjects with and without MetS (1.80 � 0.54 vs. 1.84 � 0.53 10-6 dyn-1 cm�, p = 0.55). Univariate linear regression analysis showed that AD was associated positively with male sex (p = 0.02) as well as glomerular filtration rate (p < 0.001), and negatively with age (p = 0.04), history of hypertension (p = 0.001), as well as duration of diabetes (p < 0.001). After multivariate adjustment, AD was associated independently and significantly only with age (p = 0.02), duration of diabetes p < 0.001), and history of hypertension (p = 0.004); no significant relationship was found with MetS status, the sum of the components of the MetS or the individual components-besides hypertension-of the MetS. Conclusion: In subjects with T2DM, MetS status per se is not associated with reduction of AD. In addition, it was shown that besides ageing, duration of glycemia was a strong predictor of AD. From the components of the MetS only hypertension was associated with reduction of the elastic properties of the aorta.
ACCESSION #
55716367

 

Related Articles

  • Association of HMGB1 and esRAGE levels with carotid atherosclerosis in type 2 diabetes mellitus. HU Xiao-jiao; JING Ai-yu; XIE Xuan; WU Juan-juan; ZHANG Jing; TENG Yun // Journal of Xi'an Jiaotong University (Medical Sciences);Sep2013, Vol. 34 Issue 5, preceding p638 

    Objective To explore the relationship of high mobility group box-1 protein (HMGB1) and endogenous secretory receptor for advanced glycation end products (esRAGE) with carotid atherosclerosis (AS) in type 2 diabetes mellitus (T2DM). Methods We recruited 198 hospitalized patients as the patient...

  • Fatty Liver Increases the Association of Metabolic Syndrome With Diabetes and Atherosclerosis. JUÁREZ-ROJAS, JUAN G.; MEDINA-URRUTIA, AIDA X.; JORGE-GALARZA, ESTEBAN; GONZÁLEZ-SALAZAR, CARMEN; KIMURA-HAYAMA, ERIC; CARDOSO-SALDAÑA, GUILLERMO; POSADAS-SÁNCHEZ, ROSALINDA; MARTÌNEZ-ALVARADO, ROCIO; POSADAS-ROMERO, CARLOS // Diabetes Care;Jun2013, Vol. 36 Issue 6, p1726 

    OBJECTIVE--To analyze the participation of fatty liver (FL) in the association of metabolic syndrome (MS) with type 2 diabetes and coronary artery calcification (CAC). RESEARCH DESIGN AND METHOD--A total of 765 subjects (52% women) aged 30 to 75 years without clinical atherosclerosis were...

  • Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with the Severity of Coronary Artery Disease in Chinese Women. Yuqian Bao; Zhigang Lu; Mi Zhou; Huating Li; Ye Wang; Meifang Gao; Meng Wei; Weiping Jia // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Background: Adipocyte fatty acid-binding protein (A-FABP) has been described as a novel adipokine, playing an important role in the development of metabolic syndrome, type 2 diabetes and atherosclerosis. In this study, we investigated the relationship between serum levels of A-FABP and the...

  • Impact of a community-based lifestyle intervention program on health-related quality of life. Eaglehouse, Yvonne; Schafer, Gerald; Arena, Vincent; Kramer, M.; Miller, Rachel; Kriska, Andrea; Eaglehouse, Yvonne L; Schafer, Gerald L; Arena, Vincent C; Kramer, M Kaye; Miller, Rachel G; Kriska, Andrea M // Quality of Life Research;Aug2016, Vol. 25 Issue 8, p1903 

    Background: The presence of risk factors for type 2 diabetes and cardiovascular disease, or the conditions themselves, contributes to lower health-related quality of life (HRQoL) among adults. Although community-based lifestyle intervention programs have been shown to be effective...

  • The Utility of Carotid Ultrasonography in Identifying Severe Coronary Artery Disease in Asymptomatic Type 2 Diabetic Patients Without History of Coronary Artery Disease. IRIE, YOKO; KATAKAMI, NAOTO; KANETO, HIDEAKI; NISHIO, MAYU; KASAMI, RYUICHI; SAKAMOTO, KEN'YA; UMAYAHARA, YUTAKA; SUMITSUJI, SATORU; UEDA, YASUNORI; KOSUGI, KEISUKE; SHIMOMURA, IICHIRO // Diabetes Care;May2013, Vol. 36 Issue 5, p1327 

    OBJECTIVE--Although many studies have shown that carotid intima-media thickness (IMT) is associated with coronary artery disease (CAD), it remains inconclusive whether assessment of carotid IMT is useful as a screening test for asymptomatic but severe CAD in diabetic patients. RESEARCH DESIGN...

  • Hepatic steatosis, carotid atherosclerosis and metab olic syndrome: the STEATO Study. Carallo, Claudio; Mancuso, Gerardo; Mauro, Gaetano; Laghi, Ferdinando; Madafferi, Bruno; Irace, Concetta; Gnasso, Agostino; Scavelli, Faustina; Dell’Aquila, Ferruccio; Bartone, Mosè; Gullo, Francesco; Ferraro, Maria; Spagnuolo, Vitaliano; Belmonte, Maria; Ferrara, Antonio; Rotondaro, Antonio; Brandolino, Nicola; Parasporo, Francesca; Scopelliti, Francesco // Journal of Gastroenterology;Nov2009, Vol. 44 Issue 11, p1156 

    Hepatic steatosis is frequently observed in subjects with metabolic syndrome (MS). In type 2 diabetics, it is independently associated with cardiovascular diseases. In order to confirm and extend this finding, a large group of patients with risk factors for atherosclerosis was studied. Carotid...

  • Substance in Tangerines Fights Obesity and Protects Against Heart Disease.  // Trends in Medical Research;2011, Vol. 6 Issue 4, p320 

    No abstract available.

  • Metabolic syndrome no more predictive of adulthood type 2 diabetes, atherosclerosis than BMI alone.  // Cardiology Today;Dec2010, Vol. 13 Issue 12, p23 

    The article deals with a study published in "Circulation" which found that youth with metabolic syndrome have higher risk of developing type 2 diabetes and atherosclerosis later in life.

  • Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes.  // Cardiovascular Diabetology;2011, Vol. 10 Issue 1, p72 

    The article offers information on the research conducted by the authors related to serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. It states that the study concluded serum uric acid level is associated with MetS and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics